OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
MANG57

Mangalam Organics Ltd

Diversified ChemicalsVerified

Mangalam Organics Ltd maintains a debt-to-equity ratio of 0.62, indicating a moderate level of leverage relative to its equity base. The company's liquidity position is characterized as medium risk, with a current ratio of 1.24, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. The company's cash and equivalents amount to INR 5.42 million, which is significantly lower than its long-term debt of INR 1.73 billion, resulting in a negative net cash position. In terms of profitability, the company's return on equity (ROE) is 0.92%, and its return on assets (ROA) is 0.53%, both of which are below the typical thresholds for strong performance in the Diversified Chemicals industry. The operating margin, calculated as operating income of INR 51.23 million on revenue of INR 1.05 billion, is 4.88%, which is relatively low compared to industry benchmarks. The net profit margin is 0.24%, indicating that the company is generating minimal net profit relative to its revenue. The company's revenue is primarily derived from its operations in the Diversified Chemicals industry, with no specific geographic breakdown provided in the available data. Given the lack of segment or geographic detail, it is not possible to assess the degree of revenue concentration or diversification. Looking at the company's growth trajectory, the most recent actual revenue of INR 2.39 billion suggests a significant increase from the previously reported INR 1.05 billion. However, without a clear time frame for this growth, it is difficult to determine the sustainability or pace of this increase. The company's capital expenditure of INR -399.74 million indicates a reduction in investment in long-term assets, which may signal a strategic shift or financial constraint. The risk assessment for Mangalam Organics Ltd highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could pose challenges in meeting long-term obligations. The dilution risk is considered low, with no significant changes in shares outstanding between basic and diluted figures. The company has not disclosed any recent events or filings that would indicate significant operational or financial changes.

30-day price · MANG+217.25 (+53.9%)
Low$356.25High$635.00Close$619.95As of12 May, 00:00 UTC
Profile
CompanyMangalam Organics Ltd
TickerMANG.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Mangalam Organics Ltd is a diversified chemicals company that produces and sells a range of chemical products, primarily serving the agrochemical and industrial chemical markets.

Classification. Mangalam Organics Ltd is classified under the Basic Materials economic sector, within the Chemicals business sector and Diversified Chemicals industry, with a classification confidence of 0.92.

Mangalam Organics Ltd maintains a debt-to-equity ratio of 0.62, indicating a moderate level of leverage relative to its equity base. The company's liquidity position is characterized as medium risk, with a current ratio of 1.24, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. The company's cash and equivalents amount to INR 5.42 million, which is significantly lower than its long-term debt of INR 1.73 billion, resulting in a negative net cash position. In terms of profitability, the company's return on equity (ROE) is 0.92%, and its return on assets (ROA) is 0.53%, both of which are below the typical thresholds for strong performance in the Diversified Chemicals industry. The operating margin, calculated as operating income of INR 51.23 million on revenue of INR 1.05 billion, is 4.88%, which is relatively low compared to industry benchmarks. The net profit margin is 0.24%, indicating that the company is generating minimal net profit relative to its revenue. The company's revenue is primarily derived from its operations in the Diversified Chemicals industry, with no specific geographic breakdown provided in the available data. Given the lack of segment or geographic detail, it is not possible to assess the degree of revenue concentration or diversification. Looking at the company's growth trajectory, the most recent actual revenue of INR 2.39 billion suggests a significant increase from the previously reported INR 1.05 billion. However, without a clear time frame for this growth, it is difficult to determine the sustainability or pace of this increase. The company's capital expenditure of INR -399.74 million indicates a reduction in investment in long-term assets, which may signal a strategic shift or financial constraint. The risk assessment for Mangalam Organics Ltd highlights a medium liquidity risk and a low dilution risk. The company's net cash position is negative after accounting for total debt, which could pose challenges in meeting long-term obligations. The dilution risk is considered low, with no significant changes in shares outstanding between basic and diluted figures. The company has not disclosed any recent events or filings that would indicate significant operational or financial changes.
Key takeaways
  • Mangalam Organics Ltd has a moderate level of leverage with a debt-to-equity ratio of 0.62.
  • The company's profitability metrics, including ROE and ROA, are below typical industry benchmarks.
  • The company's liquidity position is characterized as medium risk, with a current ratio of 1.24.
  • The company's net cash position is negative after accounting for total debt, indicating potential liquidity challenges.
  • The company's recent actual revenue suggests a significant increase, but the sustainability of this growth is unclear.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$1.05B
Gross profit$464.8M
Operating income$51.2M
Net income$25.7M
R&D
SG&A
D&A
SBC
Operating cash flow$731.8M
CapEx-$399.7M
Free cash flow
Total assets$4.85B
Total liabilities$2.05B
Total equity$2.81B
Cash & equivalents$5.4M
Long-term debt$1.73B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$3.38B$1.15B$847.8M$684.2M
FY-3$4.91B$760.8M$537.4M-$324.8M
FY-2$4.93B-$194.7M-$272.2M-$517.3M
FY-1$4.94B$188.4M$44.1M-$158.5M
FY0$5.30B$377.7M$126.0M-$338.6M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$3.11B$2.52B
FY-3$5.60B$3.04B
FY-2$5.06B$2.76B
FY-1$4.85B$2.81B$911.5k
FY0$6.24B$2.93B
PeriodOCFCapExFCFSBC
FY-4$262.8M-$290.4M$684.2M
FY-3-$841.0M-$999.6M-$324.8M
FY-2$769.2M-$407.7M-$517.3M
FY-1$731.8M-$399.7M-$158.5M
FY0-$78.4M-$672.7M-$338.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$1.05B$51.2M$25.7M
FQ-6$1.18B$58.2M$16.7M
FQ-5$1.38B$71.5M$21.5M
FQ-4$1.24B$106.5M$36.4M
FQ-3$1.50B$141.4M$51.4M
FQ-2$1.47B$163.9M$122.3M
FQ-1$1.58B-$93.7M$32.1M
FQ0$1.64B$135.5M$43.3M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$4.85B$2.81B$5.4M
FQ-6
FQ-5$6.04B$2.84B$5.0M
FQ-4
FQ-3$6.24B$2.93B$5.3M
FQ-2
FQ-1$7.29B$3.09B$15.1M
FQ0
PeriodOCFCapExFCFSBC
FQ-7$731.8M-$399.7M
FQ-6
FQ-5-$722.4M-$139.2M
FQ-4
FQ-3-$78.4M-$672.7M
FQ-2
FQ-1-$281.3M-$488.1M
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.81B
Net cash-$1.73B
Current ratio1.2
Debt/Equity0.6
ROA0.5%
ROE0.9%
Cash conversion28.5%
CapEx/Revenue-38.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 83 companies
MetricMANGActivity
Op margin4.9%6.3% medp25 2.1% · p75 9.6%below median
Net margin2.4%3.3% medp25 0.2% · p75 6.4%below median
Gross margin44.2%23.5% medp25 13.2% · p75 31.9%top quartile
R&D / revenue1.9% medp25 1.9% · p75 1.9%
CapEx / revenue-38.0%-5.5% medp25 -11.2% · p75 -3.8%bottom quartile
Debt / equity62.0%42.1% medp25 16.7% · p75 82.4%above median
Observations
IR observations
Last actual EPS4.64 INR
Last actual revenue2,390,966,000 INR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-12 00:34 UTC#eedf4e0c
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 12:11 UTCJob: 5fdd943f